Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Cholesterol-lowering statin approved in first markets

Dec. 11, 1996

New IGF-I variant disclosed by P&U

Dec. 11, 1996

FemPatch approved for marketing in U.S.

Dec. 10, 1996

Benzothiophene compounds for women's health disclosed by Lilly

Dec. 10, 1996

GRF analogs under study at Tulane University

Dec. 10, 1996

New calcimimetic agents from ZymoGenetics

Dec. 9, 1996

Etex signs marketing agreement for bone substitute

Dec. 6, 1996

Successful pivotal Mexican trial for oral impotency therapy

Dec. 6, 1996

Houghten's lead CRA safe in diabetics

Dec. 5, 1996

Priority review for Crinone

Dec. 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...